Microcures, Inc.
Publicly observedSanta Cruz, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Santa Cruz | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Microcures, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | KTD9TQGMNMR1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 May 2025Publicly observed
NIH SBIR/STTR award: Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2.
USD 235,898.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant15 May 2025Publicly observed
NIH SBIR/STTR award: Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2: Supplement for Imaging System
USD 44,744.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant15 May 2025Publicly observed
NIH SBIR/STTR award: Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2.
USD 458,154.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant30 Sept 2023Publicly observed
NIH SBIR/STTR award: A Novel Therapeutic to Promote Corneal Repair
USD 699,917.00 · National Eye Institute · Source: NIH RePORTER (opens in a new tab)
- Grant30 Sept 2023Publicly observed
NIH SBIR/STTR award: A Novel Therapeutic to Promote Corneal Repair
USD 699,975.00 · National Eye Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.